or Try an Advanced Search...

    Technical Analysis for IRD - Opus Genetics, Inc.

    Grade Last Price % Change Price Change
    F 0.98 10.94% 0.10
    IRD closed up 10.94 percent on Wednesday, November 20, 2024, on 1.36 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical IRD trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 10.94%
    Calm After Storm Range Contraction 10.94%
    Lower Bollinger Band Walk Weakness 10.94%
    New 52 Week Low Weakness 10.94%
    Wide Bands Range Expansion 10.94%
    Older End-of-Day Signals for IRD ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 19 hours ago
    Up 10% about 20 hours ago
    Up 1 ATR about 20 hours ago
    1.5x Volume Pace about 22 hours ago
    Gapped Up (Full) about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IRD Chart by TradingView
    Basic chart:

    Profile

    Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Greater Hartford

    Is IRD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Opus Genetics reinstated with a Buy at H.C. Wainwright
    Nov 12 Ocuphire Pharma GAAP EPS of -$0.29 misses by $0.05, revenue of $3.87M beats by $1.57M
    Nov 12 Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Oct 25 The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics
    Oct 23 Ocuphire Pharma Merges with Opus Genetics, Renamed Opus Genetics
    Oct 22 Ocuphire Pharma acquires Opus Genetics
    Oct 22 Ocuphire Pharma Announces Acquisition of Opus Genetics
    Sep 30 Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
    Sep 6 UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
    Sep 5 Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
    See more IRD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.3994
    52 Week Low 0.855
    Average Volume 139,055
    200-Day Moving Average 1.68
    50-Day Moving Average 1.23
    20-Day Moving Average 1.13
    10-Day Moving Average 1.05
    Average True Range 0.09
    RSI (14) 37.11
    ADX 29.17
    +DI 10.87
    -DI 30.75
    Chandelier Exit (Long, 3 ATRs) 1.09
    Chandelier Exit (Short, 3 ATRs) 1.12
    Upper Bollinger Bands 1.36
    Lower Bollinger Band 0.90
    Percent B (%b) 0.17
    BandWidth 40.64
    MACD Line -0.08
    MACD Signal Line -0.06
    MACD Histogram -0.0214
    Fundamentals Value
    Market Cap 23.58 Million
    Num Shares 24.1 Million
    EPS 1.44
    Price-to-Earnings (P/E) Ratio 0.68
    Price-to-Sales 1.14
    Price-to-Book 1.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.09
    Resistance 3 (R3) 1.07 1.03 1.07
    Resistance 2 (R2) 1.03 1.00 1.03 1.06
    Resistance 1 (R1) 1.00 0.98 1.02 1.02 1.06
    Pivot Point 0.96 0.96 0.96 0.96 0.96
    Support 1 (S1) 0.93 0.93 0.94 0.94 0.90
    Support 2 (S2) 0.89 0.91 0.89 0.90
    Support 3 (S3) 0.86 0.89 0.89
    Support 4 (S4) 0.87